Clinical Trial: A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Celiac Disease
Study Type: INTERVENTIONAL
Official Title: A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Brief Summary:
The goal of this clinical trial is to learn about the safety of a single dose of HB-2121 in adults.It will also look at how the body processes the drug.The main questions it aims to answer are:What side effects do participants have after receiving HB-2121?How much HB-2121 is in the blood over time?Researchers will follow participants for 30 days after receiving HB-2121 to understand how the drug behaves in the body and how safe it is.Participants will:Receive one oral dose of HB-2121Attend 4 in-person clinic…
Read more